Sequential versus standard triple first-line therapy for Helicobacter pylori eradication

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 6, 2016, Pages

  Nyssen, Olga P ^a   McNicholl, Adrian G ^a   Megraud, Francis ^b   Savarino, Vincenzo ^c   Oderda, Giuseppina ^d   Fallone, Carlo A ^e   Fischbach, Lori ^f   Bazzoli, Franco ^g   Gisbert, Javier P ^a  

^a Instituto de Investigación Sanitaria del Hospital Universitario de La Princesa   (Spain)

^b HÔPITAL PELLEGRIN   (France)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^e ROYAL VICTORIA HOSPITAL   (Canada)

^f UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^g UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; ESOMEPRAZOLE; LANSOPRAZOLE; METRONIDAZOLE; NITROIMIDAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE; TINIDAZOLE;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADVERSE OUTCOME; AFRICA; ANTIBIOTIC RESISTANCE; ASIA; BACTERIAL CLEARANCE; BITTER TASTE; BLOATING; CONFIDENCE INTERVAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL (TOPIC); DEMOGRAPHY; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG WITHDRAWAL; DYSPEPSIA; EPIGASTRIC PAIN; ERADICATION THERAPY; EUROPE; GASTROINTESTINAL SYMPTOM; GLOSSITIS; HEADACHE; HELICOBACTER INFECTION; HUMAN; INCIDENCE; INTENTION TO TREAT ANALYSIS; LINEAR REGRESSION ANALYSIS; MEDICAL INFORMATION; MEDICATION COMPLIANCE; META ANALYSIS; METALLIC TASTE; MULTICENTER STUDY (TOPIC); NAUSEA; ORAL MUCOSITIS; PEPTIC ULCER; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; REVIEW; SENSITIVITY ANALYSIS; SEQUENTIAL THERAPY; SIDE EFFECT; SOUTH AMERICA; STANDARD TRIPLE THERAPY; SYSTEMATIC REVIEW; TASTE DISORDER; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VOMITING; ADULT; COMBINATION DRUG THERAPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; MEDICAL GEOGRAPHY; PROCEDURES;

ADULT; DRUG THERAPY, COMBINATION; GEOGRAPHY, MEDICAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTENTION TO TREAT ANALYSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84976260210     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD009034.pub2     Document Type: Review

References (132)

1. Albrecht P, Kotowska M, Szajewska H. Sequential therapy compared with standard triple therapy for Helicobacter pylori eradication in children: a double-blind, randomized, controlled trial. Journal of Pediatrics 2011;159(1):45-9.
2. Ali Habib HS, Murad HA, Amir EM, Halawa TF. Effect of sequential versus standard Helicobacter pylori eradication therapy on the associated iron deficiency anemia in children. Indian Journal of Pharmacology 2013;45(5):470-3.
3. Aminian K, Farsad F, Ghanbari A, Fakhreih S, Hasheminasab SM. A randomized trial comparing four Helicobacter pylori eradication regimens: standard triple therapy, ciprofloxacin based triple therapy, quadruple and sequential therapy. Tropical Gastroenterology 2010;31(4):303-7.
4. Ang TL, Fock KM, Ang D. A randomized controlled trial of triple therapy versus sequential therapy versus concomitant therapy as first line treatment for H. Pylori infection. Gastroenterology. Conference: Digestive Disease Week 2013, DDW 2013 Orlando, FL United States 2013;144(5 Suppl 1):S53.
5. Ang TL, Fock KM, Song M, Ang D, Kwek AB, Ong J, et al. Ten-day triple therapy versus sequential therapy versus concomitant therapy as first-line treatment for Helicobacter pylori infection. Journal of Gastroenterology and Hepatology 2015;30(7):1134-9.
6. Morse AL, Goodman KJ, Munday R, Chang HJ, Morse JW, Keelan M, et al. A randomized controlled trial comparing sequential with triple therapy for Helicobacter pylori in an Aboriginal community in the Canadian north. Canadian Journal of Gastroenterology 2013;27(12):701-6.
7. Song M, Ang TL, Fock KM. An update: a randomized controlled trial of triple therapy versus sequential therapy versus concomitant therapy as first line treatment for H. Pylori infection in Singapore. Gastroenterology. Digestive Disease Week 2014, DDW 2014 2014;146(5 SUPPL. 1):S104-5.
8. Bontems P, Kalach N, Oderda G, Salame A, Muyshont L, Miendje D, et al. Sequential therapy vs. tailored triple therapies for Helicobacter pylori infection in children: A prospective, open-label, multi-center study. Journal of Pediatric Gastroenterology and Nutrition 2011;53(6):646-50.
9. Choi HS, Chun HJ, Park SH, Keum B, Seo YS, Kim YS, et al. Comparison of sequential and 7-, 10-, 14-d triple therapy for Helicobacter pylori infection. World Journal of Gastroenterology 2012;21(18/19):2377-82.
10. Chung JW, Jung YK, Kim YJ, Kwon KA, Kim JH, Lee JJ, et al. Ten-day sequential versus triple therapy for Helicobacterpylori eradication: a prospective, open-label, randomized trial. Journal of Gastroenterology and Hepatology 2012;27(11):1675-80.
11. De Francesco V, Zullo A, Margiotta M, Marangi S, Burattini O, Berloco P, et al. Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure. Alimentary Pharmacology & Therapeutics 2004;19(4):407-14.
12. De Francesco V, Zullo A, Hassan C, Della VN, Pietrini L, Minenna MF, et al. The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study. Digestive & Liver Disease 2004;36(5):322-6.
13. Eisig JN, Navarro-Rodriguez T, Teixeira AC, Silva FM, Mattar R, Chinzon D, et al. Standard triple therapy for Helicobacter pylori is still the best first line treatment in Brazil, compared with sequential therapy: a randomized, prospective, double-blind, placebo-controlledStudy. Gastroenterology. Conference: Digestive Disease Week (DDW) 2014;146(5 Suppl 1):S-390.
14. Focareta R, Forte G, Ciarlegio A. Helicobacter pylori eradication: one week triple therapy versus 10-day sequential regimen introduction. Digestive Liver Disease 2002;34:A17.
15. Focareta R, Forte G, Forte F, Ciarleglio A, Grimaldi E, Ievoli F, et al. Could the 10-days sequential therapy be considered a first choice treatment for the eradication of Helicobacter pylori infection?. Digestive and Liver Disease 2003;33:C091.
16. Franceschi F, Campanale M, Finizio R, Barbaro F, Tortora A, Gigante G, et al. High dose amoxicillin-based first line regimen is equivalent to sequential therapy in the eradication of H. pylori infection. Gastroenterology 2011;140(5):S-149.
17. Gao XZ, Qiao XL, Song WC, Wang XF, Liu F. Standard triple, bismuth pectin quadruple and sequential therapies for Helicobacter pylori eradication. World Journal of Gastroenterology 2010;16(34):4357-62.
18. Gatta L, Vakil N, Leandro G, Di Mario F, Vaira D. Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children. The American Journal of Gastroenterology 2009;104(12):3069-79.
19. Ferreccio C, Anderson GL, Morgan DR, Torres J, Bravo LE, Dominguez R, et al. A randomized trial comparing 14-day triple, 10-day sequential, and 5-day concomitant therapy to eradicate Helicobacter pylori in seven Latin American populations. AGA Abstracts 2011;NA:S-137.
20. Greenberg ER, Anderson GL, Morgan DR, Torres J, Chey WD, Bravo LE, et al. 14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial. Lancet 2011;378(9790):507-14.
21. Hsu PI, Wu DC, Chen WC, Tseng HH, Yu HC, Wang HM, et al. Randomized controlled trial comparing 7-day triple, 10-day sequential, and 7-Day concomitant therapies for Helicobacter pylori infection. Antimicrobial Agents and Chemotherapy 2014;58(10):5936-42.
22. Huang J, Zhou L, Geng L, Yang M, Xu XW, Ding ZL, et al. Randomised controlled trial: sequential vs. standard triple therapy for Helicobacter pylori infection in Chinese children-a multicentre, open-labelled study. Alimentary Pharmacology & Therapeutics 2013;38(10):1230-5.
23. Javid G, Zargar SA, Bhat K, Khan BA, Yatoo GN, Gulzar GM, et al. Efficacy and safety of sequential therapy versus standard triple therapy in Helicobacter pylori eradication in Kashmir India: a randomized comparative trial. Indian Journal of Gastroenterology 2013;32(3):190-4.
24. Choi WH, Park DI, Oh SJ, Baek YH, Hong CH, Hong EJ, et al. Effectiveness of 10 day-sequential therapy for Helicobacter pylori eradication in Korea. Taehan Sohwagi Hakhoe Chi [The Korean Journal of Gastroenterology] 2008;51(5):280-4.
25. Jeon WK, Park D. Song C. Effectiveness of 10 day-sequential treatment for Helicobacter pylori eradication in Korea. Gastroenterology 2013;144(5 Suppl. 1):S567-8.
26. Kim YS, Kim SJ, Yoon JH, Suk KT, Kim JB, Kim DJ, et al. Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy forHelicobacter pylori in Korea. Alimentary Pharmacology & Therapeutics 2011;34:1098-105.
27. Lahbabi M, Alaoui S, El Rhazi K, El Abkari M, Nejjari C, Amarti A, et al. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: Result of the HPFEZ randomised study. Clinics and Research in Hepatology and Gastroenterology 2013;37(4):416-21.
28. Laving A, Kamenwa R, Sayed S, Kimang'a AN, Revathi G. Effectiveness of sequential v. standard triple therapy for treatment of Helicobacter pylori infection in children in Nairobi, Kenya. South African Medical Journal 2013;103(12):921-4.
29. Lee JW, Kim N, Kim JM, Nam RH, Kim JY, Lee JY, et al. A comparison between 15-day sequential, 10-day sequential and proton pump inhibitor-based triple therapy for Helicobacter pylori infection in Korea. Scandinavian Journal of Gastroenterology 2014;49(8):917-24.
30. Kim J, Kim J, Kim B, Kim H, Bang B, Kim C, et al. Triple therapy, sequential therapy, and concomitant therapy for Helicobacter pylori infection in Korea: A multicenter, randomized controlled trial. Helicobacter. 27th International Workshop on Helicobacter and Microbiota in Chronic Digestive Inflammation and Gastric Cancer Rome Italy. 2014; Vol. 19:80.
31. Lee HJ, Kim JI, Lee JS, Jun EJ, Oh JH, Cheung DY, et al. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies. World Journal of Gastroenterology 2015;21(1):351-9.
32. Lim KJ, Kim JS, Kim BW, Kim CH, Kim HG, Bhang BW, et al. Triple therapy, sequential therapy, and concomitant therapy for Helicobacter pylori infection in Korea: A multicenter, randomized controlled trial. Journal of Gastroenterology and Hepatology. 2014; Vol. 29:230.
33. Liou JM, Chen CC, Chen MJ, Chang CY, Fang YJ, Lee JY, et al. Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. Lancet 2013;381(9862):205-13.
34. Liou JM, Chen CC, Chang CY, Wu JY, Fang YJ, Luo JC, et al. Sequential therapy for 10 days versus triple therapy for 14 days in the first-line treatment of Helicobacter pylori infection- a multicenter, open-label, randomized trial. Clinical Gastroenterology and Hepatology 2013;12(1):161-2.
35. Lopez-Román O, Warrington E, Cruz-Correa MR, Toro DH. 10-day and 14-day sequential therapy vs. standard triple therapy for Helicobacter pylori infection in a Puerto Rican treatment-naive population: an interim analysis. Gastroenterology 2011;140(5 Suppl 1):S149.
36. Lu JH, Xu MY, Sheng Y, Yang WX. Comparison of the efficacy of 10-day sequential therapy and conventional triple therapy for Helicobacter pylori eradication in children. Zhongguo Dang Dai Er Ke Za Zhi 2010;12:988-90.
37. Molina-Infante J, Perez-Gallardo B, Fernandez-Bermejo M, Hernandez-Alonso M, Vinagre G, Dueñas C, et al. Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication. Alimentary Pharmacology & Therapeutics 2010;31(10):1077-84.
38. Nasa M, Choksey A, Phadke A, Sawant P. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized study. Indian Journal of Gastroenterology 2013;32(6):392-6.
39. Oh HS, Lee DH, Seo JY, Cho YR, Kim N, Jeoung SH, et al. Ten-day sequential therapy is more effective than proton pump inhibitor-based therapy in Korea: A prospective, randomized study. Journal of Gastroenterology and Hepatology 2012;27(3):504-9.
40. Paoluzi OA, Visconti E, Andrei F, Tosti C, Erboso M, Lionetti RT, et al. Sequential regimens have greater efficacy and better tolerability than standard triple therapy in the eradication of Helicobacter pylori. Digestive Disease Week (AGA abstracts) 2008;M1065:A-331.
41. Paoluzi OA, Visconti E, Andrei F, Tosti C, Lionetti R, Grasso E, et al. Ten and eight-day sequential therapy in comparison to standard triple therapy for eradicating Helicobacter pylori infection: a randomized controlled study on efficacy and tolerability. Journal of Clinical Gastroenterology 2010;44(4):261-6.
42. Kim S. Park H, Jung M, Huh J, Jeon S. Ten-day sequential therapy is a promising therapeutic approach for helicobacter pylori infection in naive patients: a randomized multicenter trial. Helicobacter. 25th International Workshop on Helicobacter and Related Bacteria in Chronic Digestive Inflammation and Gastric Cancer: European Helicobacter Study Group Ljubljana Slovenia. 2012; Vol. 17:99-100.
43. Park HG, Jung MK, Jung JT, Kwon JG, Kim EY, Seo HE, et al. Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients. Alimentary Pharmacology & Therapeutics 2012;35(1):56-65.
44. Park HG, Jung MK, Jung JT, Kwon JGK, Kim EY, Eun SHE, et al. Ten-day sequential therapy is a promising therapeutic approach for Helicobacter pylori infection in naïve patients: a randomized multicenter trial. Gut 2011;60 (Suppl 3):A61.
45. Rakici H, Akdoğan RA, Bedir R, Copur A, Yilmaz A. Comparison of standard triple therapy, sequential therapy and moxifloxacin-based triple therapy for Helicobacterpylori infection: Patients' compliance and bacterial eradication rates. Journal of Digestive Diseases 2014;15(9):508-13.
46. Scaccianoce G, Hassan C, Panarese A, Piglionica D, Morini S, Zullo A. Helicobacter pylori eradication with either 7-day or 10-day triple therapies, and with a 10-day sequential regimen. Canadian Journal of Gastroenterology 2006;20(2):113-7.
47. Seddik H, Ahid S, El Adioui T, El Hamdi FZ, Hassar M, Abouqal R, et al. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a prospective randomized study. European Journal of Clinical Pharmacology 2013;69(9):1709-15.
48. Tepes B, Vujasinovic M, Seruga M, Stefanovic M, Jeverica S. Sequential and quadruple therapies for Helicobacter Pylori eradication compared with triple therapy in Slovenia: a multicenter, prospective, randomized, controlled trial. Helicobacter 2012;17:73.
49. Vaira D, Zullo A, Vakil N, Gatta L, Ricci C, Perna F, et al. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial. Annals of Internal Medicine 2007;146(8):556.
50. Wu GL, Lan Y, Zhang XJ. Sequential therapy versus standard triple therapy for Helicobacter pylori eradication. World Chinese Journal of Digestology 2011;19(29):3100-3.
51. Yan X, Zhou L, Song Z, Xue Y, Wang Y, Bai P, et al. Sequential therapy for helicobacter pylori eradication in adults compared with triple therapy in China: a multiple- centre, prospective, randomized, controlled trial. Helicobacter 2011;16(Suppl 1):77-143. Abtract WS145.142.
52. Zhou L, Zhang J, Chen M, Hou X, Li Z, Song Z, et al. A comparative study of sequential therapy and standard triple therapy for Helicobacter pylori infection: a randomized multicenter trial. American Journal of Gastroenterology 2014;109(4):535-41.
53. Zullo A, Hassan C, Lorenzetti R, Winn S, Morini S. A clinical practice viewpoint: to culture or not to culture Helicobacter pylori?. Digestive and Liver Disease 2003;35(5):357-61.
54. Zullo A, Gatta L, De Francesco V, Hassan C, Ricci C, Bernabucci V, et al. High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study. Alimentary Pharmacology & Therapeutics 2005;21(12):1419-24.
55. Francavilla R, Lionetti E, Castellaneta SP, Magista AM, Boscarelli G, Piscitelli D, et al. Improved efficacy of 10-day sequential treatment for Helicobacter pylori eradication in children: a randomized trial. Gastroenterology 2005;129(5):1414-9.
56. Hu SQ, Zhang M. A 10-day sequential therapy for Helicobacter pylori-infected patients: an analysis of 39 cases. Shi Jie Hua Ren Xiao Hua Za Zhi [World Chinese Journal of Digestology] 2009;17(16):1693-5.
57. Huang J, Gong ST, Ou WJ, Pan RF, Geng LL, Huang H, et al. A 10-day sequential therapy for eradication of Helicobacter pylori infection in children. Zhonghua Er Ke za Zhi. [Chinese Journal of Pediatrics] 2012;50(8):563-7.
58. Huang YK, Wu MC, Wang SS, Kuo CH, Lee YC, Chang LL, et al. Lansoprazole-based sequential and concomitant therapy for the first-line Helicobacter pylori eradication. Journal of Digestive Diseases 2012;13(4):232-8.
59. Kadayifci A, Uygun A, Elcin CN, Kantarcioglu M, Toros AB, Polat Z, et al. Sequential treatment regimens of H. pylori in patients with non-ulcer dyspepsia. Helicobacter 2008;13:392-479.
60. Kim JS, Kim B, Ji J, Lee B, Choi H. Sequential versus triple therapy for the treatment of Helicobacter pylori: A nationwide study. Helicobacter. 26th International Workshop on Helicobacter and Related Bacteria in Chronic Digestive Inflammation and Gastric Cancer of the European Helicobacter Study Group Madrid Spain. 2013; Vol. 18:83-4.
61. Nagahara A, Miwa H, Yamada T, Kurosawa A, Ohkura R, Sato N. Five-day proton pump inhibitor-based quadruple therapy regimen is more effective than 7-day triple therapy regimen for Helicobacter pylori infection. Alimentary Pharmacology & Therapeutics 2001;15:417-21.
62. Neville PM, Everett S, Langworthy H, Tompkins D, Mapstone NP, Axon AT, et al. The optimal antibiotic combination in a 5-day Helicobacter pylori eradication regimen. Alimentary Pharmacology & Therapeutics 1999;13(4):497-501.
63. Ntouli V, Brakas S, Zeglinas C, Charalampopoulos S, Labrinakos S, Michalopoulos G, et al. Sequential versus classical triple treatment study in a Greek population. Helicobacter 2013;18(Suppl 1):130.
64. Ruiz-Obaldía JR, Torrazza EG, Carreno NO. Helicobacter pylori eradication with either Conventional 10-day triple therapy or 10-day modified sequential regimen (preliminary report). Gastroenterology 2008;134(4 Suppl 1):A-24.
65. Torres J, Morgan DR, Greenberg ER, Salazar-Martinez E, Dominguez R, Ferreccio C, et al. One-year effectiveness and costs of six alternative H. Pylori test/treat and retest/retreat strategies using triple, concomitant or sequential drug regimens in seven Latin American Sites (SWOG Trial S0701). Gastroenterology. Digestive Diease Week 2012, DDW 2012 San Diego, CA United States 2012;142(5 Suppl 1):S115-6.
66. Urgesi R, Pelecca G, Cianci R, Masini A, Zampaletta C, Riccioni ME, et al. Helicobacter pylori infection: is sequential therapy superior to standard triple therapy? A single-centre Italian study in treatment-naive and non-treatment-naive patients. Canadian Journal of Gastroenterology 2011;25(6):315-8.
67. Uygun A, Kadayifci A, Yesilova Z, Safali M, Ilgan S, Karaeren N. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia. Clinical Therapeutics 2008;30(3):528-34.
68. Valooran GJ, Kate V, Jagdish S, Basu D. Sequential therapy versus standard triple drug therapy for eradication of Helicobacter pylori in patients with perforated duodenal ulcer following simple closure. Scandinavian Journal of Gastroenterology 2011;46(9):1045-50.
69. Zhao QX, Huang DY. Efficacy of tinidazole-containing sequential therapy in the eradication of Helicobacter pylori infection. [Chinese] [62]. [World Chinese Journal of Digestology] 2009;17(35):3666-9.
70. Altman D, Deeks J. Meta-analysis, Simpson's paradox, and the number needed to treat. BMC Medical Research Methodology 2002;2:3.
71. Calvet X, Garcia N, Lopez T, Gisbert JP, Gene E, Roque M. A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection. Alimentary Pharmacology & Therapeutics 2000;14(5):603-9.
72. Cates CJ. Simpson's paradox and calculation of number needed to treat from meta-analysis. BMC Medical Research Methodology 2002;2:1.
73. Chen Y, Wu LH, He XX. Sequential therapy versus standard triple therapy for Helicobacter pylori eradication in Chinese patients: A meta-analysis. [Chinese]. World Chinese Journal of Digestology 2009;17(32):3365-9.
74. De Francesco V, Zullo A, Hassan C, Faleo D, Ierardi E, Panella C, et al. Two new treatment regimens for Helicobacter pylori eradication: a randomised study. Digestive & Liver Disease 2001;33(8):676-9.
75. De Martel C, Parsonnet J. Helicobacter pylori infection and gender: a meta-analysis of population-based prevalence surveys. Digestive Diseases and Sciences 2006;51(12):2292-301.
76. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177-8.
77. Egger M, Smith GD, Phillips AN. Meta-analysis: principles and procedures. BMJ 1997;315(7121):1533-7.
78. Ford A, Moayyedi P. How can the current strategies for Helicobacter pylori eradication therapy be improved?. Canadian Journal of Gastroenterology 2003;17 (Suppl B):36B-40B.
79. Forman D, Bazzoli F, Bennett C, Broutet N, Calvet-Calvo X, Chiba N, et al. Therapies for the eradication of Helicobacter pylori. Cochrane Database of Systematic Reviews 2000, Issue 3. [DOI: 10.1002/14651858.CD003840.pub5]
80. Fuccio L, Minardi ME, Zagari RM, Grilli D, Magrini N, Bazzoli F. Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication. Annals of Internal Medicine 2007;147(8):553-562.
81. Gatta L, Vakil N, Leandro G, Di Mario F, Vaira D. Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children. American Journal of Gastroenterology 2009;104(12):3069-79.
82. Gisbert JP, Pajares R, Pajares JM. Evolution of Helicobacter pylori therapy from a meta-analytical perspective. Helicobacter 2007;12(Suppl 2):50-8.
83. Gisbert JP, Calvet X, ÓConnor A, Mégraud F, ÓMorain CA. Sequential therapy for Helicobacter pylori eradication. A critical review. Journal of Clinical Gastroenterology 2010;44(5):313-25.
84. Gisbert JP, Calvet X. Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough. Alimentary Pharmacology & Therapeutics 2011;34(11-12):1255-68.
85. Gisbert JP, Calvet X. Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori. Clinical and Experimental Gastroenterology 2012;5:23-4.
86. Gisbert JP, Calvet X, Bermejo F, Boixeda D, Bory F, Bujanda L, et al. [III Spanish Consensus Conference on Helicobacter pylori infection]. Gastroenterologia y Hepatologia 2013;36(5):340-74.
87. Graham DY, Lu H, Yamaoka Y. A report card to grade Helicobacter pylori therapy. Helicobacter 2007;12:275-8.
88. Graham DY, Yamaoka Y. Ethical considerations of comparing sequential and traditional anti Helicobacter pylori therapy. Annals of Internal Medicine 2007;147(6):434-5.
89. Graham DY, Lu H, Yamaoka Y. Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond. Drugs 2008;68(6):725-36.
90. Graham DY, Fischbach LA. Letter: the ethics of using inferior regimens in H. pylori randomised trials. Alimentary Pharmacology & Therapeutics 2012;35(7):852-4.
91. Gupta SK. Intention-to-treat concept: A review. Perspectives in Clinical Research 2011;2(3):109-12.
92. Haynes RB, Sackett DL, Guyatt GH, Tugwell P. Clinical Epidemiology: How to Do Clinical Practice Research. 3rd Edition. Philadelphia: Lippincott Williams & Wilkins, 2006.
93. He JD, Liu L, Zhu YJ. Ten-day sequential therapy for Helicobacter pylori eradication in children: a systematic review of randomized controlled trials. Zhonghua Yi Xue Za Zhi 2013;93(44):3500-5.
94. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21(11):1539-58.
95. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
96. Higgins JPT Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from cochrane.handbook.org.
97. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ 1999;319(7211):670-4.
98. Horvath A, Dziechciarz P, Szajewska H. Meta-analysis: sequential therapy for Helicobacter pylori eradication in children. Alimentary Pharmacology & Therapeutics 2012;36(6):534-41.
99. Hunt R, Fallone C, Veldhuyzan van Zanten S, Sherman P, Smaill F, Flook N, et al. Canadian Helicobacter Study Group Consensus Conference: update on the management of Helicobacter pylori--an evidence-based evaluation of six topics relevant to clinical outcomes in patients evaluated for H pylori infection. Canadian Journal of Gastroenterology 2004;18(9):547-54.
100. Hornung CA, Howden CW. Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment. Annals of Internal Medicine 2008;148(12):923-31.
101. Janssen MJ, Van Oijen AH, Verbeek AL, Jansen JB, De Boer WA. A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazole. Alimentary Pharmacology & Therapeutics 2001;15:613-24.
102. Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine 2001;135(11):982-98.
103. Laheij RJ, Rossum LG, Jansen JB, Straatman H, Verbeek AL. Evaluation of treatment regimens to cure Helicobacter pylori infection - a meta-analysis. Alimentary Pharmacology & Therapeutics 1999;13:857-64.
104. Lai YC, Yang JC, Huang SH. Pre-treatment urea breath test results predict the efficacy of Helicobacter pylori eradication therapy in patients with active duodenal ulcers. World Journal of Gastroenterology 2004;10(7):991-4.
105. Laine L, Fennerty MB, Osato M, Sugg MSJ, Suchower L, Probst P, et al. Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials. American Journal of Gastroenterology 2000;95:3393-8.
106. Lim JH, Lee DH, Choi C, Lee ST, Kim N, Jeong SH, et al. Clinical outcomes of two-week sequential and concomitant therapies for Helicobacter pylori eradication: a randomized pilot study. Helicobacter 2013;18(3):180-6.
107. Malfertheiner P. Current European concepts in the management of Helicobacter pylori infection. The Maastricht consensus report. Gut 1997;41(1):8-13.
108. Malfertheiner P, Megraud F, O'Morain C, Hungin AP, Jones R, Axon A, et al. Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report. Alimentary Pharmacology & Therapeutics 2002;16(2):167-80.
109. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56(6):772-81.
110. Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, et al. Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut 2012;61(5):646-64.
111. McLoughlin RM, O'Morain CA, O'Connor HJ. Eradication of Helicobacter pylori: recent advances in treatment. Fundamental and Clinical Pharmacology 2005;19(4):421-7.
112. McNicholl AG, Linares PM, Nyssen OP, Calvet X, Gisbert JP. Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection. Alimentary Pharmacology & Therapeutics 2012;36(5):414-25.
113. AG McNicholl, OP Nyssen, JP Gisbert. Sequential and concomitant treatments in H. pylori eradication: a network meta-analysis. United European Gastroenterology Journal 2014;2(1S):A64.
114. Moore RA, Gavaghan DJ, Edwards JE, Wiffen P, McQuay HJ. Pooling data for number needed to treat: no problems for apples. BMC Medical Research Methodology 2002;2:2.
115. Moshkowitz M, Konikoff FM, Peled Y, Santo M, Hallak A, Bujanover Y, et al. High Helicobacter pylori numbers are associated with low eradication rate after triple therapy. Gut 1995;36(6):845-7.
116. Moyer A, Finney JW. Rating methodological quality: toward improved assessment and investigation. Accountability in Research 2005;12(4):299-313.
117. Murakami K, Fujioka T, Okimoto T, Sato R, Kodama M, Nasu M. Drug combinations with amoxycillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapy. International Journal of Antimicrobial Agents 2002;19(1):67-70.
118. Mégraud F. H pylori antibiotic resistance: Prevalence, importance, and advances in testing. Gut 2004;53(9):1374-84.
119. Mégraud F. Helicobacter pylori and antibiotic resistance. Gut 2007;56(11):1502.
120. Mégraud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clinical Microbiology Reviews 2007;20(2):280-322.
121. Mégraud F, Coenen S, Versporten A, Kist M, Lopez-Brea M, Hirschl AM, et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut 2013;62(1):34-42.
122. Park S, Chun HJ, Kim ES, Park SC, Jung ES, Lee SD, et al. The 10-day sequential therapy for Helicobacter pylori eradication in Korea: less effective than expected. Gastroenterology 2009;136:M1053.
123. Perri F, Clemente R, Festa V, Quitadamo M, Conoscitore P, Niro G, et al. Relationship between the results of pre-treatment urea breath test and efficacy of eradication of Helicobacter pylori infection. Italian Journal of Gastroenterology and Hepatology 1998;30(2):146-50.
124. The Nordic Cochrane Centre. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, 2014.
125. Vakil N, Lanza F, Schwartz H, Barth J. Seven-day therapy for Helicobacter pylori in the United States. Alimentary Pharmacology & Therapeutics 2004;20(1):99-107.
126. Vilaichone RK, Mahachai V, Graham DY. Helicobacter pylori diagnosis and management. Gastroenterology Clinics of North America 2006;35(2):229-47.
127. Wong BCY, Chang FY, Abid S, Abbas Z, Lin BR, Van RC, et al. Triple therapy with clarithromycin, omeprazole, and amoxicillin for eradication of Helicobacter pylori in duodenal ulcer patients in Asia and Africa. Alimentary Pharmacology & Therapeutics 2000;14(11):1529-35.
128. Zullo A, Rinaldi V, Winn S, Meddi P, Lionetti R, Hassan C, et al. A new highly effective short-term therapy schedule for Helicobacter pylori eradication. Alimentary Pharmacology & Therapeutics 2000;14(6):715-8.
129. Moayyedi P. Sequential regimes for Helicobacter pylori eradication. Lancet 2007;370(9592):1010-2.
130. Nyssen OP, McNicholl AG, Megraud F, Savarino V, Oderda G, Fallone C, et al. Sequential versus standard triple therapy for Helicobacter pylori eradication. Cochrane Database of Systematic Reviews 2011, Issue 3. [DOI: 10.1002/14651858.CD009034]
131. Tong JL, Ran ZH, Shen J, Xiao SD. Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis. Journal of Clinical Pharmacy and Therapeutics 2009;34:41-53.
132. Zullo A, De Francesco V, Hassan C, Morini S, Vaira D. The sequential therapy regiment for Helicobacter pylori eradication: a pooled data analysis. Gut 2007;56(10):1353-7.